EVELO BIOSCIENCES INC (EVLO) Stock Balance Sheet
NASDAQ:EVLO - Nasdaq - US2997342025 - Common Stock - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.00M | 1.30M | 1.50M | 4.50M | 1.60M | |||
| Cash Equivalents | 15.30M | 46.70M | 67.00M | 64.40M | 76.20M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 1.70M | 3.60M | 2.60M | 2.10M | 3.20M | |||
| Total Current Assets | 18.90M | 51.60M | 71.00M | 71.00M | 81.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 900.00K | 11.70M | 15.50M | 18.20M | 8.30M | |||
| Other Non-Current Assets | 800.00K | 1.20M | 1.30M | 1.40M | 1.60M | |||
| Total Non-Current Assets | 1.70M | 12.80M | 16.90M | 19.60M | 9.90M | |||
| TOTAL ASSETS | 20.60M | 64.40M | 87.90M | 90.60M | 90.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 33.90M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 4.60M | 10.20M | 15.00M | 17.90M | 8.80M | |||
| Accounts Payable | 500.00K | 1.80M | 1.60M | 1.40M | 600.00K | |||
| Other Current Liabilities | 700.00K | 400.00K | 700.00K | 500.00K | 400.00K | |||
| Total Current Liabilities | 39.80M | 12.40M | 17.40M | 19.80M | 9.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 43.60M | 46.60M | 30.00M | 19.60M | |||
| Other Non-Current Liabilities | 7.60M | 13.40M | 15.30M | 10.30M | 1.30M | |||
| Total Non-Current Liabilities | 7.50M | 57.00M | 61.80M | 40.40M | 21.00M | |||
| TOTAL LIABILITIES | 47.30M | 69.40M | 79.20M | 60.20M | 30.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -588.00M | -529.20M | -414.70M | -292.50M | -198.90M | |||
| Additional Paid In Capital | 561.30M | 524.10M | 423.30M | 323.00M | 259.00M | |||
| Common Shares | 0.00 | 100.00K | 100.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 18.90M | 5.50M | 2.70M | 2.40M | 1.60M | |||
| Tangible Book Value per Share | -1.41 | -0.91 | 3.22 | 12.71 | 37.63 | |||
| Total Shareholders' Equity | -26.70M | -5.00M | 8.70M | 30.50M | 60.20M | |||
| TOTAL LIABILITIES AND EQUITY | 20.60M | 64.40M | 87.90M | 90.60M | 90.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | -8.72 | 5.36 | 0.98 | 0.33 | |||
| Current Ratio | 0.47 | 4.16 | 4.08 | 3.59 | 8.35 | |||
| Return On Assets (ROA) | -399.71% | -177.84% | -139.00% | -103.39% | -94.03% | |||
| Return On Equity (ROE) | N/A | N/A | -1404.37% | -307.11% | -141.98% | |||
All data in USD , ROIC based on taxRate of 0.21